Matrix Metalloproteinase-7 and ADAM-12 (a Disintegrin and Metalloproteinase-12) Define a Signaling Axis in Agonist-Induced Hypertension and Cardiac Hypertrophy
Xiang Wang(Huzhou University), Carlos Fernández-Patrón(University of Alberta), Stephan Cooper(L-3 Communications (United States)), Richard Schulz(University of Alberta), Fung L. Chow(L-3 Communications (United States)), Barry A. Finegan(University of Alberta), Gary D. Lopaschuk(University of Alberta), Sandra Kelly(L-3 Communications (United States)), Hao Li(Kunming Medical University), Tatsujiro Oka(L-3 Communications (United States)), Ana Lopez-Campistrous(University of Alberta), Zamaneh Kassiri(L-3 Communications (United States)), Jeffrey Odenbach(L-3 Communications (United States))
Cited by 83
Related Papers
Caregiving as a Risk Factor for Mortality
|JAMA|1999|3.4k
The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
|Journal of Clinical Investigation|2002|878
The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
|Journal of Clinical Investigation|2002|763
Vascular Matrix Metalloproteinase-2 Cleaves Big Endothelin-1 Yielding a Novel Vasoconstrictor
|Circulation Research|1999|364
Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix
|Cardiovascular Research|2009|287